Indian stocks: Visit www.stage2stocks.com →

USANA Health Sciences, Inc.

Stage 4 · Declining · week 9

As of Oct 22, 2026, USANA Health Sciences is in Stage 4, the downtrend phase, now in week 9 (since Aug 21, 2026). It closed at $14.52, 37.5% below its 52-week high and below its 200-day average, which is falling.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. More about the company

$14.52
+2.11% today
$268M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is USNA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 15w
S4 19w
S4 18w
S4 21w
S1 15w
S4 18w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 6w → S3 2w → S4 15w → S1 6w → S4 19w → S1 2w → S4 18w → S1 6w → S4 21w → S1 15w → S4 18w → S1 7w → S4 13w → S1 6w → S2 4w → S3 1w → S4 9w current
Total tracked: 166 weeks across 17 stage runs.

USNA among Packaged Foods38th of 65 by relative strength

All 65 →
Stocks in Packaged Foods ranked by relative strength, with stage and one-month change
#StockStageRS1M
1DARStage 2 · wk 1093−9.3%
2WESTStage 2 · wk 493+19.9%
3HLFStage 1 · wk 289+14.9%
4SENEBStage 2 · wk 3487−4.8%
5CENTStage 3 · wk 684+14.3%
6SENEAStage 2 · wk 3881−8.3%
7CENTAStage 3 · wk 681+13.6%
8SJMStage 2 · wk 1778+9.0%
…38USNAStage 4 · wk 933+3.4%
vs 52W High
-37.5%
$12.86 lo$23.24 hi
37.5% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 9
1w13w26w
Week 9, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-20.6%
200 DMA: $18.28 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
1.28x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↗ ⇈
Short-term trend rising gently, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+3.4%
3M
-31.9%
6M
-24.5%
YTD
-25.3%
1Y
-31.0%
Scan Membership
Breakout Watch
Latest: 2023-08-14
9 appearances in last 60 days. First seen: 2018-12-26.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 9 · Vol 1.28x
2026-10-21S4
Wk 9 · Vol 0.72x
2026-10-20S4
Wk 9 · Vol 0.61x
2026-10-19S4
Wk 9 · Vol 0.60x
2026-10-16S4
Wk 8 · Vol 0.99x
2026-10-15S4
Wk 8 · Vol 0.82x
2026-10-14S4
Wk 8 · Vol 1.07x
2026-10-13S4
Wk 8 · Vol 1.32x
2026-10-12S4
Wk 8 · Vol 0.97x
2026-10-09S4
Wk 7 · Vol 0.72x
2026-10-08S4
Wk 7 · Vol 0.99x
2026-10-07S4
Wk 7 · Vol 0.64x
Moving averages & range
50 DMA
$14.44
200 DMA
$18.28
52W High
$23.24
52W Low
$12.86
5D Low
$14.22
Resistance levels (recent highs)
20d High
$15.54
60d High
$22.84
120d High
$23.24
250d High
$23.24
Next resistance
+7.0%
to 20d High
ROE
-5.1%
Profit margin -2.4%
Dividend Yield
0.00%
P/B 0.5

USANA Health Sciences: quick answers

What stage is USANA Health Sciences in?

As of Oct 22, 2026, USANA Health Sciences (USNA) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 21, 2026 and is in week 9. What the four stages mean

Is USANA Health Sciences in an uptrend?

No. USANA Health Sciences is in a Stage 4 downtrend. It trades 20.6% below its 200-day average, which is falling.

How far is USANA Health Sciences from its 52-week high?

USANA Health Sciences closed at $14.52 on Oct 22, 2026, 37.5% below its 52-week high of $23.24. Its 52-week low is $12.86.

How has USANA Health Sciences performed over the past year?

As of Oct 22, 2026, USANA Health Sciences is down 31.0% over the past year and down 25.3% so far in 2026.

Which sector and industry is USANA Health Sciences in?

USANA Health Sciences is in the Packaged Foods industry, part of the Consumer Staples sector.

About this companyConsumer Staples· Packaged Foods

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.